Physician profile
Allison D Bennett
NPI 1447547047
$1,131.53
in general payments reported to CMS, 2019-2025
14 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $62.22 · 2021: $151 · 2022: $299 · 2023: $248 · 2024: $63.08 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440 · Education: $29.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $439.96 |
| Education | $29.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.35 | 2019-2023 | Liletta |
| Astellas Pharma US INC | $146.80 | 2023-2025 | Veozah |
| Organon LLC | $142.19 | 2021-2022 | |
| Pfizer INC. | $112.85 | 2020-2025 | |
| Daiichi Sankyo INC. | $110.37 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $100.73 | 2019-2025 | |
| Roche Diagnostics Corporation | $60.78 | 2019-2020 | |
| Applied Medical Resources Corporation | $60.65 | 2021 | |
| Hologic Sales and Service, LLC | $51.03 | 2019-2023 | Myosure Tissue Removal Device, Novasure |
| Intuitive Surgical, INC. | $29.24 | 2023 | |
| Gilead Sciences, INC. | $19.86 | 2019 | |
| Mayne Pharma Commercial LLC | $14.36 | 2023 | |
| Shield Therapeutics INC | $14.02 | 2023 | Accrufer |
| Agile Therapeutics, INC. | $12.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.